The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

3451–3475 of 11852

  • SevereFDA (Drugs)·D-0181-2021·2021-01-06

    Cipla Recalls Esomeprazole Magnesium Packets Due to Cross-Contamination

    Cipla is recalling 284,610 packets of Esomeprazole Magnesium delayed-release oral suspension because the excipient Crospovidone is contaminated with theophylline.

    Product
    ESOMEPRAZOLE MAGNESIUM — ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0182-2021·2021-01-06

    Cipla Recalls Esomeprazole Magnesium Suspension Due to Theophylline Contamination

    Cipla is recalling Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg due to cross-contamination with theophylline in the excipient Crospovidone.

    Product
    ESOMEPRAZOLE MAGNESIUM — ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0177-2021·2021-01-06

    Imprimis Recalls Dexamethasone-Moxifloxacin Injection Due to Sterility Concerns

    Imprimis NJOF, LLC is recalling 6,520 vials of Dexamethasone-Moxifloxacin PF Injection because 13 vials were found with faulty crimps, raising concerns about sterility.

    Product
    Dexamethasone - Moxifloxacin PF Injection (1/5) mg/mL, Imprimis Rx Volume: 1mL/vial, Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ - 07852 (844)446-6979
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0183-2021·2021-01-06

    Cipla Recalls Esomeprazole Magnesium Due to Theophylline Contamination

    Cipla is recalling specific lots of Esomeprazole Magnesium delayed-release oral suspension because the excipient Crospovidone is contaminated with theophylline.

    Product
    ESOMEPRAZOLE MAGNESIUM — ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0219-2021·2021-01-06

    Recall of Cord Care Powder Due to Cronobacter Sakazakii Contamination

    A non-sterile Cord Care Powder product was recalled because testing found Cronobacter Sakazakii contamination, posing a potential health risk without confirmed illness reports.

    Product
    Cord Care POWDER, 0.25 oz. (7 g) plastic jars, Wishgarden Herbs, Inc., Boulder, CO 80301. UPC 6-56490 24730 4
    Category
    Consumer Product
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0171-2021·2020-12-30

    SCA Pharmaceuticals Recalls Subpotent Vasopressin Injection Bags

    SCA Pharmaceuticals is recalling 654 bags of Vasopressin 20 Units in 0.9% Sodium Chloride because the drug was subpotent.

    Product
    Vasopressin 20 Units added to 0.9% Sodium Chloride 100 mL Rx Only, Single Dose Container, SCA Pharmaceuticals 8821 Knoedl Ct. Little Rock, AR 72205 Bar Code 70004093232
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0174-2021·2020-12-30

    Morton Grove Recalls Hydroxyzine Hydrochloride Oral Solution Due to Impurities

    Morton Grove Pharmaceuticals is recalling Hydroxyzine Hydrochloride Oral Solution because it failed impurity specifications, including an unknown degradant.

    Product
    Hydroxyzine Hydrochloride Oral Solution, USP (Syrup), 10 mg/5 mL, packaged in a) 4 fl oz (118 mL) bottle, NDC 60432-150-04, b) 1 pint (473 mL), NDC 60432-150-16, Rx Only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053
    Category
    Drug
    Distribution
    Distributed nationwide
  • HighFDA (Drugs)·D-0170-2021·2020-12-30

    Akebia Recalls Auryxia Tablets Due to Manufacturing Deviations

    Akebia Therapeutics is voluntarily recalling 2,170 bottles of Auryxia (ferric citrate) tablets due to CGMP deviations. The FDA classified this as a Class II recall.

    Product
    AURYXIA — AURYXIA (FERRIC CITRATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • CriticalFDA (Drugs)·D-0168-2021·2020-12-23

    AvKare Recalls Trazodone Hydrochloride Tablets Due to Sildenafil Packaging Mix-Up

    AvKare Inc. is recalling 14,368 bottles of Trazodone Hydrochloride Tablets 100 mg because they were inadvertently packaged with sildenafil.

    Product
    TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0131-2021·2020-12-23

    FDA Recalls AOD-9604 Vials Due to Sterility Concerns

    Advanced Nutriceuticals, LLC is recalling AOD-9604 vials because production processes cannot assure sterility. The product was distributed in seven states.

    Product
    AOD-9604, 1200 MCG/ML, 5 ML vial The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0137-2021·2020-12-23

    Advanced Nutriceuticals Recalls B12 Injection Vials Due to Sterility Concerns

    Advanced Nutriceuticals is recalling B12 for Injection vials because production processes cannot assure sterility. The product was distributed in seven states.

    Product
    B12 for Injection, 2 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0143-2021·2020-12-23

    Advanced Nutriceuticals Recalls LL-37 Vials Due to Sterility Concerns

    Advanced Nutriceuticals is recalling LL-37 vials because production processes cannot assure sterility. The product was distributed to seven states.

    Product
    LL-37, 2000 MCG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0138-2021·2020-12-23

    Advanced Nutriceuticals Recalls DSIP Vials Due to Sterility Concerns

    Advanced Nutriceuticals is recalling DSIP vials because production processes cannot assure sterility. The product was distributed to specific states.

    Product
    DSIP, 1000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0144-2021·2020-12-23

    Advanced Nutriceuticals Recalls Pentosan Polysulfate Vials Due to Sterility Concerns

    Advanced Nutriceuticals, LLC is recalling Pentosan Polysulfate vials because production processes cannot assure sterility. The product was distributed in seven states.

    Product
    Pentosan Polysulfate, 300 MG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0149-2021·2020-12-23

    BASF Recalls Crospovidone Excipient Due to Theophylline Contamination

    BASF Corporation is recalling 4,560 kg of Kollidon CL-M Crospovidone excipient because it was found to be cross-contaminated with theophylline.

    Product
    Kollidon CL-M Crospovidone Ph.Eur.Type B, USP/NF, JP, micronized, packaged in 30 kg plastic drums, Manufacturer: BASF SE, Carl-Bosch-Strabe 38, 67056 Ludwigshafen, Germany, Co-Manufactured by Siegfried PharmaChemikalien Minden GmbH, D-32423 Minden
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0134-2021·2020-12-23

    Advanced Nutriceuticals Recalls IPAMORELIN Vials Due to Sterility Concerns

    Advanced Nutriceuticals is recalling IPAMORELIN vials because production processes cannot assure the sterility of the product.

    Product
    IPAMORELIN, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0130-2021·2020-12-23

    PT-141 Injection Recalled Due to Sterility Assurance Concerns

    Advanced Nutriceuticals is recalling PT-141 vials because production processes cannot assure sterility. The product was distributed in seven states.

    Product
    PT-141, 10 MG/ML, 2 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0136-2021·2020-12-23

    FDA Recalls NANDROLONE Injections Due to Sterility Concerns

    Advanced Nutriceuticals, LLC is recalling NANDROLONE 200 mcg/mL injections because production processes cannot assure sterility. The recall affects vials distributed to seven states.

    Product
    NANDROLONE, 200 MCG/ML, 2 ML, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0132-2021·2020-12-23

    FDA Recalls BPC-157 Vials Due to Sterility Concerns

    Advanced Nutriceuticals, LLC is recalling BPC-157 vials because production processes cannot assure the sterility of the product.

    Product
    BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0135-2021·2020-12-23

    Advanced Nutriceuticals Recalls GHRP Vials Due to Sterility Concerns

    Advanced Nutriceuticals is recalling GHRP vials because production processes cannot assure sterility. The product was distributed in seven states.

    Product
    GHRP, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0139-2021·2020-12-23

    FDA Recalls Cerebrolysin Vials Due to Sterility Concerns

    Advanced Nutriceuticals, LLC is recalling Cerebrolysin vials because production processes cannot assure sterility. The product was distributed to seven states.

    Product
    CEREBROLYSIN, 107.5 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states
  • SevereFDA (Drugs)·D-0150-2021·2020-12-23

    Taro Recalls Clotrimazole Cream Due to Unknown Degradation Impurity

    Taro Pharmaceuticals is recalling CVS Health Athlete's Foot Cream because an unknown degradation impurity was detected slightly above the specification limit.

    Product
    CLOTRIMAZOLE 1% — CLOTRIMAZOLE 1% (CLOTRIMAZOLE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0142-2021·2020-12-23

    High Dose B12 Injection Recalled for Sterility Assurance Concerns

    Advanced Nutriceuticals is recalling High Dose B12 vials because production processes cannot assure sterility. The product was distributed in seven states.

    Product
    HIGH DOSE B12, 10 MG/ML, 10 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN
    Category
    Drug
    Distribution
    7 states